Development and in vitro evaluation of slippery nanoparticles for enhanced diffusion through native mucus

Nanomedicine

Volumn 9, Issue 3, 2014, Pages 387-396

  Laffleur, Flavia ^a   Hintzen, Fabian ^a   Shahnaz, Gul ^a   Rahmat, Deni ^a   Leithner, Katharina ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Diffusion; Mucus; Mucus penetrating; Nanoparticle; Poly(acrylic acid); Poly(allylamine)

Indexed keywords

ALLYLAMINE DERIVATIVE; LACTATE DEHYDROGENASE; NANOCARRIER; POLYACRYLIC ACID; POLYAMINE DERIVATIVE; RESAZURIN; ACRYLIC ACID RESIN; CARBOPOL 940; NANOPARTICLE; POLYALLYLAMINE; POLYAMINE;

ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIFFUSION; DRUG DIFFUSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MUCOSA; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE CHARGE; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; CACO 2 CELL LINE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECTS; METABOLISM; MUCUS; TOXICITY; ULTRASTRUCTURE;

ACRYLIC RESINS; CACO-2 CELLS; CELL SURVIVAL; DIFFUSION; DRUG DELIVERY SYSTEMS; HUMANS; MUCUS; NANOPARTICLES; PARTICLE SIZE; POLYAMINES;

EID: 84898956187     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.26     Document Type: Article

References (28)

1. Sandhiya S, Dkhar SA, Surendiran A. Emerging trends of nanomedicine - an overview. Fundam. Clin. Pharmacol. 23(3), 263-269 (2009).
2. Prego C, Garcia M, Torres D, Alonso MJ. Transmucosal macromolecular drug delivery. J. Control. Release 101(1-3), 151-162 (2005).
3. Olmsted SS, Padgett JL, Yudin AI, Whaley KJ, Moench TR, Cone RA. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys. J. 81(4), 1930-1937 (2001).
4. Thornton DJ, Sheehan JK. From mucins to mucus: toward a more coherent understanding of this essential barrier. Proc. Am. Thorac. Soc. 1(1), 54-61 (2004).
5. Carlstedt I, Sheehan JK. Structure and macromolecular properties of cervical mucus glycoproteins. Symp. Soc. Exp. Biol. 43, 289-316 (1989).
6. Cone RA. Barrier properties of mucus. Adv. Drug Deliver. Rev. 61(2), 75-85 (2009).
7. Lai SK, O'Hanlon DE, Harrold S et al. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc. Natl Acad. Sci. USA 104(5), 1482-1487 (2007).
8. Lai SK, Wang YY, Hanes J. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv. Drug Deliver. Rev. 61(2), 158-171 (2009).
9. Ai H, Jones SA, Lvov YM. Biomedical applications of electrostatic layer-by-layer nano-assembly of polymers, enzymes, and nanoparticles. Cell Biochem. Biophys. 39(1), 23-43 (2003).
10. Bertrand P, Jonas A, Laschewsky A, Legras R. Ultrathin polymer coatings by complexation of polyelectrolytes at interfaces: suitable materials, structure and properties. Macromol. Rapid Comm. 21(7), 319-348 (2000).
11. Calvo P, Remunanlopez C, Vilajato JL, Alonso MJ. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci. 63(1), 125-132 (1997).
12. Bravo-Osuna I, Schmitz T, Bernkop-Schnurch A, Vauthier C, Ponchel G. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles. Int. J. Pharm. 316(1-2), 170-175 (2006).
13. Schmitz T, Bravo-Osuna I, Vauthier C, Ponchel G, Loretz B, Bernkop-Schnurch A. Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery system. Biomaterials 28(3), 524-531 (2007).
14. Deutel B, Greindl M, Thaurer M, Bernkop-Schnurch A. Novel insulin thiomer nanoparticles: in vivo evaluation of an oral drug delivery system. Biomacromolecules 9(1), 278-285 (2008).
15. Albrecht K, Zirm EJ, Palmberger TF, Schlocker W, Bernkop-Schnurch A. Preparation of thiomer microparticles and in vitro evaluation of parameters influencing their mucoadhesive properties. Drug Dev. Ind. Pharm. 32(10), 1149-1157 (2006).
16. Loretz B, Bernkop-Schnurch A. In vitro cytotoxicity testing of non-thiolated and thiolated chitosan nanoparticles for oral gene delivery. Nanotoxicology 1(2), 139-148 (2007).
17. Rahmat D, Sakloetsakun D, Shahnaz G, Sarti F, Laffleur F, Schnurch AB. HEC-cysteamine conjugates: influence of degree of thiolation on efflux pump inhibitory and permeation enhancing properties. Int. J. Pharm. 422(1-2), 40-46 (2012).
18. Crater JS, Carrier RL. Barrier properties of gastrointestinal mucus to nanoparticle transport. Macromol. Biosci. 10(12), 1473-1483 (2010).
19. Douglas KL, Tabrizian M. Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier. J. Biomater. Sci. Polym. Ed. 16(1), 43-56 (2005).
20. Rajaonarivony M, Vauthier C, Couarraze G, Puisieux F, Couvreur P. Development of a new drug carrier made from alginate. J. Pharm. Sci. 82(9), 912-917 (1993).
21. Younessi P, Avadi MR, Shamimi K et al. Preparation and ex vivo evaluation of TEC as an absorption enhancer for poorly absorbable compounds in colon specific drug delivery. Acta Pharm. 54(4), 339-345 (2004).
22. Mawad D, Lauto A, Penciu A et al. Synthesis and characterization of novel radiopaque poly(allyl amine) nanoparticles. Nanotechnology 21(33), 335603 (2010).
23. Mao S, Shuai X, Unger F, Wittmar M, Xie X, Kissel T. Synthesis, characterization and cytotoxicity of poly(ethylene glycol)-graft-trimethyl chitosan block copolymers. Biomaterials 26(32), 6343-6356 (2005).
24. Vigl C, Leithner K, Albrecht K, Bernkop-Schnurch A. The efflux pump inhibitory properties of (thiolated) polyallylamines. J. Drug Deliv. Sci. Tec. 19(6), 405-411 (2009).
25. Vetter A, Perera G, Leithner K, Klima G, Bernkop-Schnurch A. Development and in vivo bioavailability study of an oral fondaparinux delivery system. Eur. J. Pharm. Sci. 41(3-4), 489-497 (2010).
26. Bernkop-Schnurch A, Weithaler A, Albrecht K, Greimel A. Thiomers: preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system. Int. J. Pharm. 317(1), 76-81 (2006).
27. Larhed AW, Artursson P, Grasjo J, Bjork E. Diffusion of drugs in native and purified gastrointestinal mucus. J. Pharm. Sci. 86(6), 660-665 (1997).
28. Suk JS, Lai SK, Boylan NJ, Dawson MR, Boyle MP, Hanes J. Rapid transport of muco-inert nanoparticles in cystic fibrosis sputum treated with N-acetyl cysteine. Nanomedicine (Lond. ) 6(2), 365-375 (2011).